0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nuclear Medicine Cyclotron Systems Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-11I15571
Home | Market Reports | Health
Global Nuclear Medicine Cyclotron Systems Market Research Report 2023
BUY CHAPTERS

Global Nuclear Medicine Cyclotron Systems Market Research Report 2025

Code: QYRE-Auto-11I15571
Report
March 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nuclear Medicine Cyclotron Systems Market Size

The global market for Nuclear Medicine Cyclotron Systems was valued at US$ 232 million in the year 2024 and is projected to reach a revised size of US$ 312 million by 2031, growing at a CAGR of 4.4% during the forecast period.

Nuclear Medicine Cyclotron Systems Market

Nuclear Medicine Cyclotron Systems Market

Nuclear Medicine Cyclotron Systems are specialized devices used in the field of nuclear medicine for the production of short-lived radioisotopes. These systems consist of a cyclotron, which is a type of particle accelerator, and associated equipment for radioisotope production. Cyclotrons accelerate charged particles, typically protons, to high speeds and direct them at target materials, resulting in the creation of radioisotopes used in various medical imaging and therapeutic applications. The produced radioisotopes play a crucial role in positron emission tomography (PET) scans and other diagnostic and treatment procedures in nuclear medicine, aiding in the visualization and characterization of physiological processes within the human body.
Global core manufacturers of Nuclear Medicine Cyclotron Systems include GE Healthcare, Best Cyclotron Systems and Advanced Cyclotron Systems (ACSI). The top three companies have a market share of about 65%. Asia Pacific is the largest global market for Nuclear Medicine Cyclotron Systems with a market share of approximately 34%, followed by North America and Europe with a market share of 29% and 22%, respectively. In terms of product type, Cyclotron 13-18 MeV is the largest segment with approximately 42% market share. In terms of application, Hospital is the largest downstream segment, accounting for about 60% of the market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine Cyclotron Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine Cyclotron Systems.
The Nuclear Medicine Cyclotron Systems market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Medicine Cyclotron Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine Cyclotron Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nuclear Medicine Cyclotron Systems Market Report

Report Metric Details
Report Name Nuclear Medicine Cyclotron Systems Market
Accounted market size in year US$ 232 million
Forecasted market size in 2031 US$ 312 million
CAGR 4.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Cyclotron Less than 12 MeV
  • Cyclotron 13-18 MeV
  • Cyclotron 19-24 MeV
  • Cyclotron More than 24 MeV
Segment by Application
  • Pharmaceutical Industry
  • Hospital
  • Research & Academics
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GE Healthcare, IBA, Best Cyclotron Systems, Advanced Cyclotron Systems (ACSI), Sumitomo Heavy Industries, Longevous Beamtech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nuclear Medicine Cyclotron Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nuclear Medicine Cyclotron Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Nuclear Medicine Cyclotron Systems Market growing?

Ans: The Nuclear Medicine Cyclotron Systems Market witnessing a CAGR of 4.4% during the forecast period 2025-2031.

What is the Nuclear Medicine Cyclotron Systems Market size in 2031?

Ans: The Nuclear Medicine Cyclotron Systems Market size in 2031 will be US$ 312 million.

What is the market share of major companies in Nuclear Medicine Cyclotron Systems Market?

Ans: The top three companies have a market share of about 65%.

What is the Nuclear Medicine Cyclotron Systems Market share by region?

Ans: Asia Pacific is the largest global market for Nuclear Medicine Cyclotron Systems with a market share of approximately 34%, followed by North America and Europe with a market share of 29% and 22%, respectively.

What is the Nuclear Medicine Cyclotron Systems Market share by type?

Ans: In terms of product type, Cyclotron 13-18 MeV is the largest segment with approximately 42% market share.

What is the Nuclear Medicine Cyclotron Systems Market share by application?

Ans: In terms of application, Hospital is the largest downstream segment, accounting for about 60% of the market share.

Who are the main players in the Nuclear Medicine Cyclotron Systems Market report?

Ans: The main players in the Nuclear Medicine Cyclotron Systems Market are GE Healthcare, IBA, Best Cyclotron Systems, Advanced Cyclotron Systems (ACSI), Sumitomo Heavy Industries, Longevous Beamtech

What are the Application segmentation covered in the Nuclear Medicine Cyclotron Systems Market report?

Ans: The Applications covered in the Nuclear Medicine Cyclotron Systems Market report are Pharmaceutical Industry, Hospital, Research & Academics

What are the Type segmentation covered in the Nuclear Medicine Cyclotron Systems Market report?

Ans: The Types covered in the Nuclear Medicine Cyclotron Systems Market report are Cyclotron Less than 12 MeV, Cyclotron 13-18 MeV, Cyclotron 19-24 MeV, Cyclotron More than 24 MeV

Recommended Reports

Nuclear Medicine

Cyclotron & Accelerators

Radioisotopes & Therapies

1 Nuclear Medicine Cyclotron Systems Market Overview
1.1 Product Definition
1.2 Nuclear Medicine Cyclotron Systems by Type
1.2.1 Global Nuclear Medicine Cyclotron Systems Market Value Comparison by Type (2024 VS 2031)
1.2.2 Cyclotron Less than 12 MeV
1.2.3 Cyclotron 13-18 MeV
1.2.4 Cyclotron 19-24 MeV
1.2.5 Cyclotron More than 24 MeV
1.3 Nuclear Medicine Cyclotron Systems by Application
1.3.1 Global Nuclear Medicine Cyclotron Systems Market Value by Application (2024 VS 2031)
1.3.2 Pharmaceutical Industry
1.3.3 Hospital
1.3.4 Research & Academics
1.4 Global Nuclear Medicine Cyclotron Systems Market Size Estimates and Forecasts
1.4.1 Global Nuclear Medicine Cyclotron Systems Revenue 2020-2031
1.4.2 Global Nuclear Medicine Cyclotron Systems Sales 2020-2031
1.4.3 Global Nuclear Medicine Cyclotron Systems Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nuclear Medicine Cyclotron Systems Market Competition by Manufacturers
2.1 Global Nuclear Medicine Cyclotron Systems Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nuclear Medicine Cyclotron Systems Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nuclear Medicine Cyclotron Systems, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nuclear Medicine Cyclotron Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nuclear Medicine Cyclotron Systems, Product Type & Application
2.7 Global Key Manufacturers of Nuclear Medicine Cyclotron Systems, Date of Enter into This Industry
2.8 Global Nuclear Medicine Cyclotron Systems Market Competitive Situation and Trends
2.8.1 Global Nuclear Medicine Cyclotron Systems Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nuclear Medicine Cyclotron Systems Players Market Share by Revenue
2.8.3 Global Nuclear Medicine Cyclotron Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nuclear Medicine Cyclotron Systems Market Scenario by Region
3.1 Global Nuclear Medicine Cyclotron Systems Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nuclear Medicine Cyclotron Systems Sales by Region: 2020-2031
3.2.1 Global Nuclear Medicine Cyclotron Systems Sales by Region: 2020-2025
3.2.2 Global Nuclear Medicine Cyclotron Systems Sales by Region: 2026-2031
3.3 Global Nuclear Medicine Cyclotron Systems Revenue by Region: 2020-2031
3.3.1 Global Nuclear Medicine Cyclotron Systems Revenue by Region: 2020-2025
3.3.2 Global Nuclear Medicine Cyclotron Systems Revenue by Region: 2026-2031
3.4 North America Nuclear Medicine Cyclotron Systems Market Facts & Figures by Country
3.4.1 North America Nuclear Medicine Cyclotron Systems Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nuclear Medicine Cyclotron Systems Sales by Country (2020-2031)
3.4.3 North America Nuclear Medicine Cyclotron Systems Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nuclear Medicine Cyclotron Systems Market Facts & Figures by Country
3.5.1 Europe Nuclear Medicine Cyclotron Systems Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nuclear Medicine Cyclotron Systems Sales by Country (2020-2031)
3.5.3 Europe Nuclear Medicine Cyclotron Systems Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nuclear Medicine Cyclotron Systems Market Facts & Figures by Region
3.6.1 Asia Pacific Nuclear Medicine Cyclotron Systems Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nuclear Medicine Cyclotron Systems Sales by Region (2020-2031)
3.6.3 Asia Pacific Nuclear Medicine Cyclotron Systems Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.7 Latin America Nuclear Medicine Cyclotron Systems Market Facts & Figures by Country
3.7.1 Latin America Nuclear Medicine Cyclotron Systems Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nuclear Medicine Cyclotron Systems Sales by Country (2020-2031)
3.7.3 Latin America Nuclear Medicine Cyclotron Systems Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nuclear Medicine Cyclotron Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Nuclear Medicine Cyclotron Systems Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nuclear Medicine Cyclotron Systems Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nuclear Medicine Cyclotron Systems Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Nuclear Medicine Cyclotron Systems Sales by Type (2020-2031)
4.1.1 Global Nuclear Medicine Cyclotron Systems Sales by Type (2020-2025)
4.1.2 Global Nuclear Medicine Cyclotron Systems Sales by Type (2026-2031)
4.1.3 Global Nuclear Medicine Cyclotron Systems Sales Market Share by Type (2020-2031)
4.2 Global Nuclear Medicine Cyclotron Systems Revenue by Type (2020-2031)
4.2.1 Global Nuclear Medicine Cyclotron Systems Revenue by Type (2020-2025)
4.2.2 Global Nuclear Medicine Cyclotron Systems Revenue by Type (2026-2031)
4.2.3 Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Type (2020-2031)
4.3 Global Nuclear Medicine Cyclotron Systems Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nuclear Medicine Cyclotron Systems Sales by Application (2020-2031)
5.1.1 Global Nuclear Medicine Cyclotron Systems Sales by Application (2020-2025)
5.1.2 Global Nuclear Medicine Cyclotron Systems Sales by Application (2026-2031)
5.1.3 Global Nuclear Medicine Cyclotron Systems Sales Market Share by Application (2020-2031)
5.2 Global Nuclear Medicine Cyclotron Systems Revenue by Application (2020-2031)
5.2.1 Global Nuclear Medicine Cyclotron Systems Revenue by Application (2020-2025)
5.2.2 Global Nuclear Medicine Cyclotron Systems Revenue by Application (2026-2031)
5.2.3 Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Application (2020-2031)
5.3 Global Nuclear Medicine Cyclotron Systems Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Company Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Nuclear Medicine Cyclotron Systems Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GE Healthcare Nuclear Medicine Cyclotron Systems Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 IBA
6.2.1 IBA Company Information
6.2.2 IBA Description and Business Overview
6.2.3 IBA Nuclear Medicine Cyclotron Systems Sales, Revenue and Gross Margin (2020-2025)
6.2.4 IBA Nuclear Medicine Cyclotron Systems Product Portfolio
6.2.5 IBA Recent Developments/Updates
6.3 Best Cyclotron Systems
6.3.1 Best Cyclotron Systems Company Information
6.3.2 Best Cyclotron Systems Description and Business Overview
6.3.3 Best Cyclotron Systems Nuclear Medicine Cyclotron Systems Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Best Cyclotron Systems Nuclear Medicine Cyclotron Systems Product Portfolio
6.3.5 Best Cyclotron Systems Recent Developments/Updates
6.4 Advanced Cyclotron Systems (ACSI)
6.4.1 Advanced Cyclotron Systems (ACSI) Company Information
6.4.2 Advanced Cyclotron Systems (ACSI) Description and Business Overview
6.4.3 Advanced Cyclotron Systems (ACSI) Nuclear Medicine Cyclotron Systems Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Advanced Cyclotron Systems (ACSI) Nuclear Medicine Cyclotron Systems Product Portfolio
6.4.5 Advanced Cyclotron Systems (ACSI) Recent Developments/Updates
6.5 Sumitomo Heavy Industries
6.5.1 Sumitomo Heavy Industries Company Information
6.5.2 Sumitomo Heavy Industries Description and Business Overview
6.5.3 Sumitomo Heavy Industries Nuclear Medicine Cyclotron Systems Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sumitomo Heavy Industries Nuclear Medicine Cyclotron Systems Product Portfolio
6.5.5 Sumitomo Heavy Industries Recent Developments/Updates
6.6 Longevous Beamtech
6.6.1 Longevous Beamtech Company Information
6.6.2 Longevous Beamtech Description and Business Overview
6.6.3 Longevous Beamtech Nuclear Medicine Cyclotron Systems Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Longevous Beamtech Nuclear Medicine Cyclotron Systems Product Portfolio
6.6.5 Longevous Beamtech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nuclear Medicine Cyclotron Systems Industry Chain Analysis
7.2 Nuclear Medicine Cyclotron Systems Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nuclear Medicine Cyclotron Systems Production Mode & Process Analysis
7.4 Nuclear Medicine Cyclotron Systems Sales and Marketing
7.4.1 Nuclear Medicine Cyclotron Systems Sales Channels
7.4.2 Nuclear Medicine Cyclotron Systems Distributors
7.5 Nuclear Medicine Cyclotron Systems Customer Analysis
8 Nuclear Medicine Cyclotron Systems Market Dynamics
8.1 Nuclear Medicine Cyclotron Systems Industry Trends
8.2 Nuclear Medicine Cyclotron Systems Market Drivers
8.3 Nuclear Medicine Cyclotron Systems Market Challenges
8.4 Nuclear Medicine Cyclotron Systems Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Nuclear Medicine Cyclotron Systems Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Nuclear Medicine Cyclotron Systems Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Nuclear Medicine Cyclotron Systems Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Nuclear Medicine Cyclotron Systems Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global Nuclear Medicine Cyclotron Systems Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Nuclear Medicine Cyclotron Systems Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Nuclear Medicine Cyclotron Systems Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Nuclear Medicine Cyclotron Systems Average Price (M US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Nuclear Medicine Cyclotron Systems, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Nuclear Medicine Cyclotron Systems, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Nuclear Medicine Cyclotron Systems, Product Type & Application
 Table 12. Global Key Manufacturers of Nuclear Medicine Cyclotron Systems, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Nuclear Medicine Cyclotron Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Cyclotron Systems as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Nuclear Medicine Cyclotron Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Nuclear Medicine Cyclotron Systems Sales by Region (2020-2025) & (Units)
 Table 18. Global Nuclear Medicine Cyclotron Systems Sales Market Share by Region (2020-2025)
 Table 19. Global Nuclear Medicine Cyclotron Systems Sales by Region (2026-2031) & (Units)
 Table 20. Global Nuclear Medicine Cyclotron Systems Sales Market Share by Region (2026-2031)
 Table 21. Global Nuclear Medicine Cyclotron Systems Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Region (2020-2025)
 Table 23. Global Nuclear Medicine Cyclotron Systems Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Region (2026-2031)
 Table 25. North America Nuclear Medicine Cyclotron Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Nuclear Medicine Cyclotron Systems Sales by Country (2020-2025) & (Units)
 Table 27. North America Nuclear Medicine Cyclotron Systems Sales by Country (2026-2031) & (Units)
 Table 28. North America Nuclear Medicine Cyclotron Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Nuclear Medicine Cyclotron Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Nuclear Medicine Cyclotron Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Nuclear Medicine Cyclotron Systems Sales by Country (2020-2025) & (Units)
 Table 32. Europe Nuclear Medicine Cyclotron Systems Sales by Country (2026-2031) & (Units)
 Table 33. Europe Nuclear Medicine Cyclotron Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Nuclear Medicine Cyclotron Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Nuclear Medicine Cyclotron Systems Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Nuclear Medicine Cyclotron Systems Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific Nuclear Medicine Cyclotron Systems Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific Nuclear Medicine Cyclotron Systems Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Nuclear Medicine Cyclotron Systems Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Nuclear Medicine Cyclotron Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Nuclear Medicine Cyclotron Systems Sales by Country (2020-2025) & (Units)
 Table 42. Latin America Nuclear Medicine Cyclotron Systems Sales by Country (2026-2031) & (Units)
 Table 43. Latin America Nuclear Medicine Cyclotron Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Nuclear Medicine Cyclotron Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Nuclear Medicine Cyclotron Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Nuclear Medicine Cyclotron Systems Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa Nuclear Medicine Cyclotron Systems Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa Nuclear Medicine Cyclotron Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Nuclear Medicine Cyclotron Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Nuclear Medicine Cyclotron Systems Sales (Units) by Type (2020-2025)
 Table 51. Global Nuclear Medicine Cyclotron Systems Sales (Units) by Type (2026-2031)
 Table 52. Global Nuclear Medicine Cyclotron Systems Sales Market Share by Type (2020-2025)
 Table 53. Global Nuclear Medicine Cyclotron Systems Sales Market Share by Type (2026-2031)
 Table 54. Global Nuclear Medicine Cyclotron Systems Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Nuclear Medicine Cyclotron Systems Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Type (2020-2025)
 Table 57. Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Type (2026-2031)
 Table 58. Global Nuclear Medicine Cyclotron Systems Price (M US$/Unit) by Type (2020-2025)
 Table 59. Global Nuclear Medicine Cyclotron Systems Price (M US$/Unit) by Type (2026-2031)
 Table 60. Global Nuclear Medicine Cyclotron Systems Sales (Units) by Application (2020-2025)
 Table 61. Global Nuclear Medicine Cyclotron Systems Sales (Units) by Application (2026-2031)
 Table 62. Global Nuclear Medicine Cyclotron Systems Sales Market Share by Application (2020-2025)
 Table 63. Global Nuclear Medicine Cyclotron Systems Sales Market Share by Application (2026-2031)
 Table 64. Global Nuclear Medicine Cyclotron Systems Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Nuclear Medicine Cyclotron Systems Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Application (2020-2025)
 Table 67. Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Application (2026-2031)
 Table 68. Global Nuclear Medicine Cyclotron Systems Price (M US$/Unit) by Application (2020-2025)
 Table 69. Global Nuclear Medicine Cyclotron Systems Price (M US$/Unit) by Application (2026-2031)
 Table 70. GE Healthcare Company Information
 Table 71. GE Healthcare Description and Business Overview
 Table 72. GE Healthcare Nuclear Medicine Cyclotron Systems Sales (Units), Revenue (US$ Million), Price (M US$/Unit) and Gross Margin (2020-2025)
 Table 73. GE Healthcare Nuclear Medicine Cyclotron Systems Product
 Table 74. GE Healthcare Recent Developments/Updates
 Table 75. IBA Company Information
 Table 76. IBA Description and Business Overview
 Table 77. IBA Nuclear Medicine Cyclotron Systems Sales (Units), Revenue (US$ Million), Price (M US$/Unit) and Gross Margin (2020-2025)
 Table 78. IBA Nuclear Medicine Cyclotron Systems Product
 Table 79. IBA Recent Developments/Updates
 Table 80. Best Cyclotron Systems Company Information
 Table 81. Best Cyclotron Systems Description and Business Overview
 Table 82. Best Cyclotron Systems Nuclear Medicine Cyclotron Systems Sales (Units), Revenue (US$ Million), Price (M US$/Unit) and Gross Margin (2020-2025)
 Table 83. Best Cyclotron Systems Nuclear Medicine Cyclotron Systems Product
 Table 84. Best Cyclotron Systems Recent Developments/Updates
 Table 85. Advanced Cyclotron Systems (ACSI) Company Information
 Table 86. Advanced Cyclotron Systems (ACSI) Description and Business Overview
 Table 87. Advanced Cyclotron Systems (ACSI) Nuclear Medicine Cyclotron Systems Sales (Units), Revenue (US$ Million), Price (M US$/Unit) and Gross Margin (2020-2025)
 Table 88. Advanced Cyclotron Systems (ACSI) Nuclear Medicine Cyclotron Systems Product
 Table 89. Advanced Cyclotron Systems (ACSI) Recent Developments/Updates
 Table 90. Sumitomo Heavy Industries Company Information
 Table 91. Sumitomo Heavy Industries Description and Business Overview
 Table 92. Sumitomo Heavy Industries Nuclear Medicine Cyclotron Systems Sales (Units), Revenue (US$ Million), Price (M US$/Unit) and Gross Margin (2020-2025)
 Table 93. Sumitomo Heavy Industries Nuclear Medicine Cyclotron Systems Product
 Table 94. Sumitomo Heavy Industries Recent Developments/Updates
 Table 95. Longevous Beamtech Company Information
 Table 96. Longevous Beamtech Description and Business Overview
 Table 97. Longevous Beamtech Nuclear Medicine Cyclotron Systems Sales (Units), Revenue (US$ Million), Price (M US$/Unit) and Gross Margin (2020-2025)
 Table 98. Longevous Beamtech Nuclear Medicine Cyclotron Systems Product
 Table 99. Longevous Beamtech Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Nuclear Medicine Cyclotron Systems Distributors List
 Table 103. Nuclear Medicine Cyclotron Systems Customers List
 Table 104. Nuclear Medicine Cyclotron Systems Market Trends
 Table 105. Nuclear Medicine Cyclotron Systems Market Drivers
 Table 106. Nuclear Medicine Cyclotron Systems Market Challenges
 Table 107. Nuclear Medicine Cyclotron Systems Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nuclear Medicine Cyclotron Systems
 Figure 2. Global Nuclear Medicine Cyclotron Systems Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nuclear Medicine Cyclotron Systems Market Share by Type: 2024 & 2031
 Figure 4. Cyclotron Less than 12 MeV Product Picture
 Figure 5. Cyclotron 13-18 MeV Product Picture
 Figure 6. Cyclotron 19-24 MeV Product Picture
 Figure 7. Cyclotron More than 24 MeV Product Picture
 Figure 8. Global Nuclear Medicine Cyclotron Systems Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Nuclear Medicine Cyclotron Systems Market Share by Application: 2024 & 2031
 Figure 10. Pharmaceutical Industry
 Figure 11. Hospital
 Figure 12. Research & Academics
 Figure 13. Global Nuclear Medicine Cyclotron Systems Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Nuclear Medicine Cyclotron Systems Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Nuclear Medicine Cyclotron Systems Sales (2020-2031) & (Units)
 Figure 16. Global Nuclear Medicine Cyclotron Systems Average Price (M US$/Unit) & (2020-2031)
 Figure 17. Nuclear Medicine Cyclotron Systems Report Years Considered
 Figure 18. Nuclear Medicine Cyclotron Systems Sales Share by Manufacturers in 2024
 Figure 19. Global Nuclear Medicine Cyclotron Systems Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Nuclear Medicine Cyclotron Systems Players: Market Share by Revenue in Nuclear Medicine Cyclotron Systems in 2024
 Figure 21. Nuclear Medicine Cyclotron Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Nuclear Medicine Cyclotron Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Nuclear Medicine Cyclotron Systems Sales Market Share by Country (2020-2031)
 Figure 24. North America Nuclear Medicine Cyclotron Systems Revenue Market Share by Country (2020-2031)
 Figure 25. United States Nuclear Medicine Cyclotron Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Nuclear Medicine Cyclotron Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Nuclear Medicine Cyclotron Systems Sales Market Share by Country (2020-2031)
 Figure 28. Europe Nuclear Medicine Cyclotron Systems Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Nuclear Medicine Cyclotron Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Nuclear Medicine Cyclotron Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Nuclear Medicine Cyclotron Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Nuclear Medicine Cyclotron Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Nuclear Medicine Cyclotron Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Nuclear Medicine Cyclotron Systems Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Nuclear Medicine Cyclotron Systems Revenue Market Share by Region (2020-2031)
 Figure 36. China Nuclear Medicine Cyclotron Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Nuclear Medicine Cyclotron Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Nuclear Medicine Cyclotron Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Nuclear Medicine Cyclotron Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Nuclear Medicine Cyclotron Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Nuclear Medicine Cyclotron Systems Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Nuclear Medicine Cyclotron Systems Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Nuclear Medicine Cyclotron Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Nuclear Medicine Cyclotron Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Nuclear Medicine Cyclotron Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Nuclear Medicine Cyclotron Systems Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Nuclear Medicine Cyclotron Systems Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Nuclear Medicine Cyclotron Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Nuclear Medicine Cyclotron Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. U.A.E Nuclear Medicine Cyclotron Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Nuclear Medicine Cyclotron Systems by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Nuclear Medicine Cyclotron Systems by Type (2020-2031)
 Figure 53. Global Nuclear Medicine Cyclotron Systems Price (M US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Nuclear Medicine Cyclotron Systems by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Nuclear Medicine Cyclotron Systems by Application (2020-2031)
 Figure 56. Global Nuclear Medicine Cyclotron Systems Price (M US$/Unit) by Application (2020-2031)
 Figure 57. Nuclear Medicine Cyclotron Systems Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners